A detailed history of Cozad Asset Management Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Cozad Asset Management Inc holds 20,881 shares of NVO stock, worth $2.49 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
20,881
Previous 16,418 27.18%
Holding current value
$2.49 Million
Previous $2.11 Million 41.37%
% of portfolio
0.3%
Previous 0.22%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

BUY
$122.71 - $146.91 $547,654 - $655,659
4,463 Added 27.18%
20,881 $2.98 Million
Q1 2024

May 08, 2024

BUY
$102.11 - $135.92 $127,433 - $169,628
1,248 Added 8.23%
16,418 $2.11 Million
Q4 2023

Feb 05, 2024

BUY
$87.78 - $105.45 $376,400 - $452,169
4,288 Added 39.4%
15,170 $1.57 Million
Q3 2023

Nov 02, 2023

BUY
$90.94 - $199.54 $552,460 - $1.21 Million
6,075 Added 126.38%
10,882 $989,000
Q2 2023

Jul 26, 2023

SELL
$155.98 - $172.65 $53,813 - $59,564
-345 Reduced 6.7%
4,807 $777,000
Q1 2023

May 01, 2023

SELL
$132.34 - $159.14 $4,764 - $5,729
-36 Reduced 0.69%
5,152 $819,000
Q4 2022

Feb 07, 2023

SELL
$102.55 - $135.33 $3,691 - $4,871
-36 Reduced 0.69%
5,188 $702,000
Q2 2022

Aug 09, 2022

SELL
$103.24 - $121.81 $19,615 - $23,143
-190 Reduced 3.51%
5,224 $582,000
Q1 2022

Apr 29, 2022

BUY
$93.1 - $112.54 $13,034 - $15,755
140 Added 2.65%
5,414 $601,000
Q1 2021

Apr 29, 2021

SELL
$67.06 - $75.82 $12,070 - $13,647
-180 Reduced 3.3%
5,274 $356,000
Q4 2019

Jan 16, 2020

SELL
$49.86 - $58.26 $10,470 - $12,234
-210 Reduced 3.71%
5,454 $316,000
Q1 2019

Apr 18, 2019

SELL
$46.36 - $52.63 $3,152 - $3,578
-68 Reduced 1.19%
5,664 $296,000
Q4 2018

Jan 14, 2019

BUY
$41.54 - $47.25 $1,495 - $1,701
36 Added 0.63%
5,732 $264,000
Q3 2018

Nov 13, 2018

SELL
$46.76 - $51.24 $79,492 - $87,108
-1,700 Reduced 22.99%
5,696 $269,000
Q2 2018

Aug 15, 2018

BUY
$44.29 - $50.42 $327,568 - $372,906
7,396 New
7,396 $341,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $269B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Cozad Asset Management Inc Portfolio

Follow Cozad Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cozad Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cozad Asset Management Inc with notifications on news.